Results 251 to 260 of about 1,513,041 (341)

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

Journal of Internal Medicine, Volume 299, Issue 2, Page 228-240, February 2026.
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis, Quentin Astouati, Lucas Pacoureau, Yann Nguyen, Pierre Bay, Antoine Roux, Laure Gallay, Vincent Cottin, Benjamin Terrier, Alain Meyer, Charles Cerf, Mathilde Neuville, Baptiste Hervier, Arthur Renaud, Benoit Suzon, Nicolas Schleinitz, Thomas Papo, Pascaline Priou, Arsène Mekinian, Audrey Ullmer, Erwan Oehler, Noémie Gensous, Alice Berezne, Luc De Saint Martin, Thierry Marhadour, Mickaël Martin, Amélie Servettaz, Maxime Samson, Laurent Gilardin, Pierre Charles, Juliette Woessner, Thierry Carmoi, Baptiste Dilly, Wladimir Mauhin, Nicolas Baillet, Sébastien Humbert, Benjamin Thoreau, Marine Lemaitre, Claire Le Pendu, Pierre Loiseau, Thomas Quemeneur, Elodie Blanchard, Nicol Voermans, David Launay, Hilario Nunes, Olivier Benveniste, Yurdagul Uzunhan, Yves Allenbach   +47 more
wiley   +1 more source

What is the role of antinuclear antibody tests in diagnosing systemic rheumatic diseases?

Tripdatabase
openalex   +1 more source

Measurement of serum antinuclear antibody titer in dogs with and without systemic lupus erythematosus: 120 cases (1997–2005) [PDF]

, 2007
Nicole Smee, Kenneth R. Harkin, Melinda J. Wilkerson   +2 more
openalex   +1 more source

Differences in Dynamics of Specific Antinuclear Antibodies and Their Susceptibility to B Cell-Targeting Treatment in Patients With Systemic Lupus Erythematosus. [PDF]

Arthritis Rheumatol
van Dooren HJ, van Schaik M, Dorjée AL, Arends EJ, Mackay M, Cooney L, Fox DA, Wofsy D, Smilek D, Aranow C, Dall'Era M, Huizinga TWJ, van Kooten C, Toes REM, Diamond B, Teng YKO, Suurmond J.   +16 more
europepmc   +1 more source

Ischemic Stroke in Hypereosinophilic Syndrome: A Clinicopathologic Study of Two Cases

Neuropathology, Volume 46, Issue 1, February 2026.
ABSTRACT Ischemic stroke is a rare complication of hypereosinophilic syndrome (HES). Manifestations of stroke in HES have been described in the radiologic literature; however the pathologic characterization of central nervous system (CNS) involvement in HES is limited.
Karina C. Martin, Dan Straathof, Chi Lai, Harry V. Vinters   +3 more
wiley   +1 more source

The Prevalence of Antinuclear Antibodies in the General Population of China: A Cross-Sectional Study

Current Therapeutic Research, 2014
Yaping Guo, Chun-guang Wang, Xin Liu, Yi-Qian Huang, De-li Guo, X. Jing, C. Yuan, Song Yang, Jin-mei Liu, Mengsi Han, Hong-xing Li   +10 more
semanticscholar   +1 more source

Prevalence of Antinuclear Antibodies in Patients With Coronary Artery Disease: A Scoping Review. [PDF]

Cureus
Antony M, Thymalil C, Nagy S, Amini K, Kesselman MM.   +4 more
europepmc   +1 more source

Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients. [PDF]

Hum Reprod
Yoshihara H, Goto S, Kitaori T, Sugiura-Ogasawara M.   +3 more
europepmc   +1 more source

A Further Exploration of the Impact of Antinuclear Antibodies on In Vitro Fertilization–Embryo Transfer Outcome

American Journal of Reproductive Immunology, 2013
Y. Ying, Yiping Zhong, Canquan Zhou, Yan-wen Xu, C. Ding, Qiong Wang, Jie Li, Xiaoting Shen   +7 more
semanticscholar   +1 more source

Present condition of molecular immunodiagnosis. Antinuclear antibody.

, 1995
橋本 博史
openalex   +2 more sources